📋 SELLAS LIFE SCIENCES GROUP, INC. (SLS) - Financial Results
Filing Date: 2026-03-19
Accepted: 2026-03-19 16:08:36
Event Type: Financial Results
Event Details:
SELLAS LIFE SCIENCES GROUP, INC. (SLS) Reports the reporting period Financial Results
SELLAS LIFE SCIENCES GROUP, INC. (SLS) announced its financial results for the period ending the reporting period.
Key Financial Highlights:
Revenue: Not disclosed
Net Income: Not disclosed
EPS: Not disclosed
Cash and equivalents: 100
anticipated in Q2 2026
anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties with oncology product development and clinical success thereof, the uncertainty of regulatory approval, and other risks and uncertainties affecting SELLAS and its development programs as set forth under the caption “Risk Factors” in SELLAS’ Annual Report on Form 10-K filed on March 19, 2026
📋 SELLAS LIFE SCIENCES GROUP, INC. (SLS) - Financial Results
Filing Date: 2026-03-19
Accepted: 2026-03-19 16:08:36
Event Type: Financial Results
Event Details:
📊 Key Financial Metrics (Year-over-Year Comparison):
💼 Business Developments:
Structured Data: